摘要
Topoisomerase inhibitors have been developed in a variety of clinical applications. We investigated the inhibitory effect of evodiamine on E. coli topoisomerase I, which may lead to an anti-bacterial effect. Evodiamine inhibits the supercoiled plasmid DNA relaxation that is catalyzed by E. coli topoisomerase I, and computer-aided docking has shown that the Arg161 and Asp551 residues of topoisomerase I interact with evodiamine. We investigated the bactericidal effect of evodiamine against multidrug-resistant Klebsiella pneumoniae. Evodiamine showed a significantly lower minimal inhibitory concentration value (MIC 128 μg/mL) compared with antibiotics (> 512 μg/mL) against the clinical isolate of K. pneumoniae. The results suggested that evodiamine is a potential agent against drug-resistant bacteria.
原文 | 英語 |
---|---|
頁(從 - 到) | 27-29 |
頁數 | 3 |
期刊 | Planta Medica |
卷 | 79 |
發行號 | 1 |
DOIs | |
出版狀態 | 已發佈 - 2013 |
ASJC Scopus subject areas
- 補充和替代醫學
- 分子醫學
- 有機化學
- 分析化學
- 藥學科學
- 藥理
- 藥物發現